Back

Platelet reactivity index after treatment of clopidogrel versus ticagrelor based on CYP2C19 genotypes among patients undergoing percutaneous coronary intervention: results of a randomized study

1 December 2022 (17:48 - 18:00)
Organised by:
Congress Presentation Part of: Young Investigator Award Competition Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Asia 2022 with APSC & AFC

About the speaker

Photo
Doctor Mohammed Ahmed Al-Kaif

Universiti Sains Malaysia, Gelugor, Penang (Malaysia)

3 More presentations in this session

Presentation thumbnail
Differential expression of TLR4 in patients of coronary artery disease with and without traditional cardiovascular risk factors
Doctor N. Biswas (Kolkata, IN)
Abstract Video
Presentation thumbnail
Sex difference in neurological outcome and post-cardiac arrest care in out-of-hospital cardiac arrest patients treated with targeted temperature management
Doctor S. Park (Seoul, KR)
Abstract Video
Presentation thumbnail
Interplay between post-myocardial infarction ejection fraction and atrial fibrillation: implications for ischemic stroke
Doctor J. Ho (Singapore, SG)
Abstract Video

Access the full session

Session thumbnail
Young Investigator Award Competition
Video

The Event

Event poster

ESC Asia 2022 with APSC & AFC

1 December 2022 17:48 CET
You may be interested in
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
thumbnail
ESC TV Today
Episode 7: Coronary spasm - Sex differences in heart failure
thumbnail
Congress Session
Challenges in hypertension management

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources